News and Announcements
Brookfield not planning to make an offer for Hikma Pharmaceuticals
By Michele Maatouk
Date: Wednesday 04 Feb 2026
(Sharecast News) - Brookfield confirmed on Wednesday that it does not plan on making an offer for Hikma Pharmaceuticals.
The brief statement was made in response to recent speculation.
Article Archive
- 2026-04-02 - Air France-KLM submits bid for stake in Portugal's TAP
- 2026-04-02 - Sorted Group proposes to dispose of its main trading subsidiary
- 2026-04-02 - Atalaya Mining takes stake in Canada's Lara Exploration for CAD $13.5m
- 2026-04-02 - Lloyds holds £1.95bn payout provision for motor finance scandal
- 2026-04-02 - Merchants Trust posts positive but underperforming year
- 2026-04-01 - Rightmove facing £1.5bn legal action, shares tumble
- 2026-04-01 - Derwent sells Horseferry House in London for £132m
- 2026-04-01 - Babcock shares surge on UK govt contract, Citi upgrade
- 2026-04-01 - Berkeley refreshes strategy, reiterates FY26 PBT guidance
- 2026-03-31 - Eli Lilly to buy Centessa Pharmaceuticals for up to $7.8bn
- 2026-03-31 - Biogen to buy Apellis Pharmaceuticals in $5.6bn deal
- 2026-03-31 - Microsoft faces UK probe into business software 'ecosystem'
- 2026-03-31 - SigmaRoc secures EUR 825m refinancing facility
- 2026-03-31 - Rosebank Industries plans move from AIM to Main Market
- 2026-03-31 - Dominos Pizza Group makes Nicola Frampton its permanent CEO
- 2026-03-31 - Hilton Food Group confident in strategy as profits fall
- 2026-03-31 - Pets at Home reaffirms guidance, shares jump
- 2026-03-31 - Altitude flags full-year revenue ahead of market expectations
- 2026-03-31 - Unilever nearing deal to merge food business with McCormick
- 2026-03-31 - AG Barr hails 'pleasing' performance from core brands as FY profits rise
- 2026-03-31 - Raspberry Pi shares surge 47% as profit beats expectations
- 2026-03-31 - Eurozone inflation jumps to 2.5% in March as energy prices surge
- 2026-03-30 - Fusion Antibodies enters deal to transfer IP to client
- 2026-03-30 - CVS chief stepping down for 'personal reasons'
- 2026-03-30 - HICL Infrastructure increases Thameslink rolling‑stock stake with £52m acquisition
- 2026-03-30 - FCA says millions of drivers to get average £830 car finance payout
- 2026-03-27 - Prosus reportedly mulling Delivery Hero stake sale to Aspex
- 2026-03-27 - Petards subsidiary secures two contracts
- 2026-03-27 - Harbour Energy slumps as BASF sells 80m shares in placing
- 2026-03-27 - Metlen Energy shares fall after annual results delayed
- 2026-03-26 - Brown-Forman and Pernod Ricard confirm merger talks
- 2026-03-26 - Israel says it killed Iranian naval commander
- 2026-03-26 - US open: Stocks lower as Middle East tensions remain in focus
- 2026-03-26 - NS&I expected to repay millions to customers and bereaved families
- 2026-03-26 - Shares jump as Treatt reiterates full-year guidance
- 2026-03-26 - Henkel to buy US premium haircare brand Olaplex in $1.4bn deal
- 2026-03-26 - Shares in Boliden plunge as Swedish mine hit by seismic activity
- 2026-03-26 - Oxford Biomedica reiterates full-year guidance, flags first-half loss
- 2026-03-26 - Avingtrans subsidiary submits 20th quantum computing magnet
- 2026-03-26 - Capita to sell private sector contact centre business to Inspirit Capital, shares surge
- 2026-03-26 - Arbuthnot posts 'resilient' performance as profits fall
- 2026-03-26 - Mears lifts dividend, grows profits despite flat top line
- 2026-03-26 - Edenred shares tank as Italian regulator launches market abuse probe
- 2026-03-26 - Ceres Power slides deeper into the red
- 2026-03-26 - Playtech shares slide as FY revenues miss, Evolution uncertainty weighs
- 2026-03-26 - 3i reports steady performance at Action, shares fall
- 2026-03-26 - Annual sales, profits surge at Next
- 2026-03-26 - THG back in the black following improved H2 performance
- 2026-03-26 - German consumer sentiment slumps as Iran war sparks inflation fears
- 2026-03-26 - UK consumer confidence slips as 'ripple of fear' spreads, says GfK
- 2026-03-25 - Meta lays off 'hundreds' across wearables, ads divisions
- 2026-03-25 - Nexus Infrastructure flags resilient full-year performance
- 2026-03-25 - FCA unveils plans to make financial advice more accessible, affordable
- 2026-03-25 - Merck to buy Terns Pharmaceuticals for $6.7bn
- 2026-03-25 - Norman Broadbent returns to profit in strong full-year performance
- 2026-03-25 - Pinewood Technologies lowers earnings guidance on delay to Marshalls rollout
- 2026-03-25 - United Utilities FY adjusted EPS seen in line with previous guidance
- 2026-03-25 - Rio Tinto secures AUD2bn bailout for Boyne aluminium smelter
- 2026-03-25 - Diageo sells stake in Indian cricket team RCB for £1.3bn
- 2026-03-25 - Annual revenues, profits jump at Eurowag
- 2026-03-25 - Great Portland Estates reaches practical completion at 2 Aldermanbury Square
- 2026-03-24 - RAC Group said to be sounding out investors for London IPO
- 2026-03-24 - Alternative Income REIT confirms takeover approach from AEW UK REIT
- 2026-03-24 - Ascent Resources awaiting timing clarity in its claim against Slovenia
- 2026-03-24 - PPHC reports strong revenue growth, record adjusted earnings
- 2026-03-24 - Bank of London fined £2m for multiple failings
- 2026-03-24 - YouGov warns on profits, shares slide
- 2026-03-24 - S4 shares surge on revenue outlook despite Iran war
- 2026-03-24 - Annual revenues, profits surge at Staffline
- 2026-03-24 - Xaar reports return to profitability
- 2026-03-24 - Trustpilot tanks as Advent Global offloads 21.6m shares in placing
- 2026-03-24 - Trustpilot appoints The Economist Group's Marcus Roy as CFO
- 2026-03-24 - Vet prescription charges to be capped in sector overhaul
- 2026-03-24 - Bytes Technology sees flat operating profit in 2027, shares tank
- 2026-03-24 - Bellway hikes interim dividend after robust H1 performance despite uncertain outlook
- 2026-03-24 - Gamma Communications reports revenue growth, profit decline
- 2026-03-23 - Estee Lauder confirms merger talks with Spain's Puig
- 2026-03-23 - Entain surges as US prediction market faces potential sports ban
- 2026-03-23 - TheraCryf lead Ox-1 programme advances to final toxicology studies
- 2026-03-23 - Spire still in talks with other parties as Triton, Bridgepoint abandon pursuit
- 2026-03-23 - PPHE inks £136m loan deal with Bank Hapoalim on Park Plaza hotel
- 2026-03-20 - Triton and Bridgepoint abandon pursuit of Spire Healthcare
- 2026-03-20 - Ascent Resources enters binding licence deal with Neometals vehicle
- 2026-03-20 - Supermicro co-founder charged with smuggling tech to China, shares plunge
- 2026-03-20 - Novartis snaps up Synnovation's breast-cancer treatment for up to $3bn
- 2026-03-20 - Spire Healthcare surges on report of £1bn Bridgepoint offer
- 2026-03-20 - Unilever confirms offer from McCormick for foods business
- 2026-03-19 - Crypto.com to lay off 12% of workforce in AI push
- 2026-03-19 - OpenAI to take over Astral for undisclosed sum
- 2026-03-19 - Fulham Shore exploring possible restructuring of The Real Greek chain
Free Membership To Digital Look
Discover the full range of Investor's Tools and Services from Digital Look - voted 'Best Research & Information Provider 2007' by Investors Chronicle.
En HeaderFooterDLYou are here: research